DK2355853T3 - Bionedbrydelige polymer-bioaktivt fragmentkonjugater - Google Patents
Bionedbrydelige polymer-bioaktivt fragmentkonjugater Download PDFInfo
- Publication number
- DK2355853T3 DK2355853T3 DK09818693.5T DK09818693T DK2355853T3 DK 2355853 T3 DK2355853 T3 DK 2355853T3 DK 09818693 T DK09818693 T DK 09818693T DK 2355853 T3 DK2355853 T3 DK 2355853T3
- Authority
- DK
- Denmark
- Prior art keywords
- bioactive
- polymer
- moiety
- monomer
- biodegradable polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/34—Carboxylic acids; Esters thereof with monohydroxyl compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/30—Low-molecular-weight compounds
- C08G18/38—Low-molecular-weight compounds having heteroatoms other than oxygen
- C08G18/3819—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen
- C08G18/3842—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen containing heterocyclic rings having at least one nitrogen atom in the ring
- C08G18/3848—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen containing heterocyclic rings having at least one nitrogen atom in the ring containing two nitrogen atoms in the ring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/4269—Lactones
- C08G18/4277—Caprolactone and/or substituted caprolactone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/428—Lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
- C08G18/771—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/16—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G67/00—Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing oxygen or oxygen and carbon, not provided for in groups C08G2/00 - C08G65/00
- C08G67/04—Polyanhydrides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2230/00—Compositions for preparing biodegradable polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Polyurethanes Or Polyureas (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyesters Or Polycarbonates (AREA)
- Biological Depolymerization Polymers (AREA)
- Dental Preparations (AREA)
Claims (20)
1. Bionedbrydelig polymer omfattende en flerhed af frigivelige bioaktive fragmenter, hvor de frigivelige bioaktive fragmenter er vedhængende fra og kovalent bundet til det bionedbrydelige polymerskelet, hvor den bionedbrydelige polymer har en generel formel (I):
(I) hvor: A og B, der er det samme eller forskellige, repræsenterer det resterende af polymerskelettet og (i) omfatter en eller flere -X-R(ZD)-Y- som vist i formel (I), og (ii) er hver dannet af monomerenheder der er koblet via et bionedbrydeligt fragment, hvor hver X, Y, R, Z og D i et givet -X-R(ZD)-Y- fragment af den bionedbrydelige polymer er det samme eller forskellige; X og Y er hver uafhængigt et bionedbrydeligt fragment valgt fra et estereller karbamatfragment; R repræsenterer et lineært eller forgrenet eventuelt substitueret carbonhydrid; Z er et spacerfragment; og D er et frigiveligt bioaktivt fragment valgt fra fluoroquinolon antibiotika, hvor de bioaktive fragmenter (D) er i stand til at blive frigivet ved en hastighed lig med eller hurtigere end hastigheden af bionedbrydning af polymerskelettet.
2. Den bionedbrydelige polymer ifølge krav 1, hvor de bioaktive fragmenter (D) er valgt fra alatrofloxacin, balofloxacin, ciprofloxacin, clinafloxacin, danofoxacin, delafloxacin, dextrofloxacin, difloxacin, enoxacin, enrofloxacin, garenoxacin, gatifloxacin, gemifloxacin, grepafloxacin, levofloxacin, lomefloxacin, marbofloxacin, moxifloxacin, nadifloxacin, norfloxacin, ofloxacin, orbifloxacin, pefloxacin, sitafloxacin, sparfloxacin, temafloxacin, tosufloxacin, tosulfloxacin og trovafloxacin.
3. Den bionedbrydelige polymer ifølge krav 1 eller krav 2, hvor A og B er valgt fra polyurethaner, polyestere, og copolymerer deraf.
4. Den bionedbrydelige polymer ifølge et hvilket som helst af kravene 1 til 3, hvilken omfatter mindre end 25 mol% af polymeriserede rester der er afledt fra en C2-diol, i forhold til det samlede antal mol af polymeriserede diolrester.
5. Den bionedbrydelige polymer ifølge et hvilket som helst af kravene 1 til 4, hvor D er koblet via Z til R af et ester-, amid-, thiol-, anhydrid-, imid-, karbonat-, peroxid-, peroxyester-, fosfatester-, thioester-, sulfatester-, karbamat-, azo- eller boronatesterfragment.
6. Den bionedbrydelige polymer ifølge krav 5, hvor Z er valgt fra gruppen bestående af oxy (-0-), alkyl, alkenyl, alkynyl, aryl, acyl (including -C(O)-), carbocyclyl, heterocyclyl, heteroaryl, alkyloxy, alkenyloxy, alkynyloxy, aryloxy, acyloxy, carbocyclyloxy, heterocyclyloxy, heteroaryloxy, alkylthio, alkenylthio, alkynylthio, arylthio, acylthio, carbocyclylthio, heterocyclylthio, heteroarylthio, alkylalkenyl, alkylalkynyl, alkylaryl, alkylacyl, alkylcarbocyclyl, alkylheterocyclyl, alkylheteroaryl, alkyloxyalkyl, alkenyloxyalkyl, alkynyloxyalkyl, aryloxyalkyl, alkylacyloxy, alkyloxyacylalkyl, alkylcarbocyclyloxy, alkylheterocyclyloxy, alkylheteroaryloxy, alkylthioalkyl, alkenylthioalkyl, alkynylthioalkyl, arylthioalkyl, alkylacylthio, alkylcarbocyclylthio, alkylheterocyclylthio, alkylheteroarylthio, alkylalkenylalkyl, alkylalkynylalkyl, alkylarylalkyl, alkylacylalkyl, arylalkylaryl, arylalkenylaryl, arylalkynylaryl, arylacylaryl, arylacyl, arylcarbocyclyl, arylheterocyclyl, arylheteroaryl, alkenyloxyaryl, alkynyloxyaryl, aryloxyaryl, arylacyloxy, arylcarbocyclyloxy, arylheterocyclyloxy, arylheteroaryloxy, alkylthioaryl, alkenylthioaryl, alkynylthioaryl, arylthioaryl, arylacylthio, arylcarbocyclylthio, arylheterocyclylthio, og arylheteroarylthio, hvor når til stede den eller hver -CH2-gruppe i en hvilken som helst alkylkæde kan erstattes afen divalentgruppe uafhængigt valgt fra -O-, -0P(0)2-, -0P(0)20- -S-, -S(O)-, -S(0)20-, -0S(0)20-, -N = N-, -0Si(0Ra)20-, -Si(0Ra)20-, -0B(0Ra)0-, -B(0Ra)0-, -NRa-, -C(O)-, -C(0)0-, -0C(0)0-, -0C(0)NRa- og -C(0)NRa-, hvor den eller hver Ra kan være uafhængigt valgt fra hydrogen, alkyl, alkenyl, alkynyl, aryl, carbocyclyl, heteroaryl, heterocyclyl, arylalkyl, og acyl.
7. Den bionedbrydelige polymer ifølge krav 5 eller krav 6, hvor Z er valgt fra -O-; -C(O)-; og eventuelt substitueret: -0C(0)-Ci-i8alkylen-C(0)-; -C(0)0-Ci-i8alkylen-C(0)-; -NRaC(0)-Ci-i8alkylen-C(0)-; -C(0)0-Ci-i8alkylen-0-; -O-Ci-lealkylen-O-; -O-Ci-isalkylen-NR3-; -0C(0)-Ci-i8alkylen-NRa-; -C(0)-Ci-i8alkylen-NRa-; -0C(0)-Ci-i8alkylen-0-; -C(0)-Ci-i8alkylen-0-; og -C(0)NRa-Ci-i8alkylen-NRa- hvor Ra er valgt fra hydrogen, Ci-isalkyl, Ci-isalkenyl, Ci-isalkynyl, C6-isaryl, C3-i8carbocyclyl, C3-isheteroaryl, C3-i8heterocyclyl, og C7-isarylalkyl.
8. Den bionedbrydelige polymer ifølge et hvilket som helst af kravene 5 til 7, hvor Z er valgt fra -O-; -C(O)-; og -0C(0)-Ci-i8alkylen-C(0)-, såsom -0C(0)-C2-3alkylen-C(0)-.
9. Den bionedbrydelige polymer ifølge et hvilket som helst af kravene 1 til 8, hvor R er et lineært eller forgrenet eventuelt substitueret carbonhydrid med fra 1 til 12 kulstofatomer.
10. Den bionedbrydelige polymer ifølge et hvilket som helst af kravene 1 til 9, hvor R er aromatisk.
11. Den bionedbrydelige polymer ifølge krav 6, hvor, Z er aryloxy.
12. Den bionedbrydelige polymer ifølge krav 6, hvor Z er arylacyloxy.
13. Den bionedbrydelige polymer ifølge et hvilket som helst af kravene 1 til 10, opnåelig ved polymerisering af et monomer-bioaktivt fragmentkonjugat af formel (II):
(Π) hvor: X' og V er hver uafhængige funktionelle grupper der (a) er i stand til at undergå polymerisering med monomer med kompatibel kemisk funktionalitet, og (b) reagere med den kompatible kemiske funktionalitet for at give et bionedbrydeligt fragment, hvor X' og V er hver uafhængigt valgt fra hydroxyl, carboxylsyre, isocyanat, og carboxylsyrehalid; R repræsenterer et lineært eller forgrenet eventuelt substitueret carbonhydrid; Z er et spacerfragment; og D er et frigiveligt bioaktivt fragment valgt fra fluoroquinolon antibiotika; med mindst en monomer omfattende kompatibel kemisk funktionalitet.
14. Bionedbrydelig polymer ifølge krav 13, opnåelig ved polymerisering af det monomer-bioaktivt fragmentkonjugat af formel II, hvor substituenterne X' og Y' er hver hydroxyl, med et diisocyanat frembringende en polyurethan.
15. Bionedbrydelig polymer ifølge krav 13, opnåelig ved polymerisering af det monomer-bioaktive fragmentkonjugat af formel (II) hvor X' og Y' er hver hydroxyl med et polyisocyanat, en polysyre eller polyester, der kan finde sted i tilstedeværelsen af en eller flere andre typer af polyoler.
16. Bionedbrydelig polymer ifølge krav 15, hvor den ene eller flere andre typer af polyoler er polyesterpolyoler.
17. Bionedbrydelig polymer ifølge krav 15 eller krav 16, hvor polyisocyanatet er valgt fra m-phenylen diisocyanat, p-phenylen diisocyanat, 2,4-toluen diisocyanat, 2,6-toluen diisocyanat, 1,6-hexamethylen diisocyanat, 1,4-hexamethylen diisocyanat, 1,3-cyclohexan diisocyanat, 1,4-cyclohexan diisocyanat, hexahydro-toluen diisocyanat og dets isomerer, isophoron diisocyanat, dicyclo-hexylmethan diisocyanater, 1,5-napthylen diisocyanat, 4,4'-diphenylmethan diisocyanat, 2,4' diphenylmethan diisocyanat, 4,4'-biphenylen diisocyanat, 3,3'-dimethoxy-4,4'-biphenylen diisocyanat, 3,3'-dimethyl-diphenylpropan-4,4'-diisocyanat, 2,4,6-toluen triisocyanat, 4,4'-dimethyl-diphenylmethan-2,2',5,5,-tetraisocyanat, polymethylen polyphenyl-polyisocyanater og alkylestere af lysin diisocyanat.
18. Fremgangsmåde til at fremstille en bionedbrydelig polymer ifølge et hvilket som helst af kravene valgt fra 1 til 10 og 13 til 16, hvilken fremgangsmåde omfatter trinnet at polymerisere et monomer-bioaktivt fragmentkonjugat af formel (II):
(Π) hvor: X' og V er hver uafhængige funktionelle grupper der (a) er i stand til at undergå polymerisering med monomer med kompatibel kemisk funktionalitet, og (b) reagere med den kompatible kemiske funktionalitet for at give et bionedbrydeligt fragment, hvor X' og V er hver uafhængigt valgt fra hydroxyl, carboxylsyre, isocyanat, og carboxylsyrehalid; og R, Z og D er som defineret i et hvilket som helst af kravene valgt fra 1 til 10 og 13 til 17; med mindst en monomer omfattende kompatibel kemisk funktionalitet.
19. Monomer-bioaktivt fragmentkonjugat der er egnet til anvendelse i fremstilling af en bionedbrydelig polymer, hvor det monomer-bioaktive fragmentkonjugat har en struktur af general formel (II):
(Π) hvor: X' og V er hver uafhængige funktionelle grupper der (a) er i stand til at undergå polymerisering med monomer med kompatibel kemisk funktionalitet for at danne en bionedbrydelig polymer, og (b) reagere med den kompatible kemiske funktionalitet for at give et bionedbrydeligt fragment, hvor X' og V er hver hydroxyl og den kompatible kemiske funktionalitet er et diisocyanat og frembringer en polyurethan; R repræsenterer et lineært eller forgrenet eventuelt substitueret carbonhydrid; Z er et spacerfragment; og D er valgt fra fluoroquinolon antibiotika.
20. Monomer-bioaktivt fragmentkonjugat ifølge krav 19, hvor de bioaktive fragmenter (D) er valgt fra alatrofloxacin, balofloxacin, ciprofloxacin, clinafloxacin, danofoxacin, delafloxacin, dextrofloxacin, difloxacin, enoxacin, enrofloxacin, garenoxacin, gatifloxacin, gemifloxacin, grepafloxacin, levofloxacin, lomefloxacin, marbofloxacin, moxifloxacin, nadifloxacin, norfloxacin, ofloxacin, orbifloxacin, pefloxacin, sitafloxacin, sparfloxacin, temafloxacin, tosufloxacin, tosulfloxacin og trovafloxacin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008905263A AU2008905263A0 (en) | 2008-10-10 | Drug polymer conjugates | |
PCT/AU2009/001342 WO2010040188A1 (en) | 2008-10-10 | 2009-10-09 | Biodegradable polymer - bioactive moiety conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2355853T3 true DK2355853T3 (da) | 2017-03-06 |
Family
ID=42100154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09818693.5T DK2355853T3 (da) | 2008-10-10 | 2009-10-09 | Bionedbrydelige polymer-bioaktivt fragmentkonjugater |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP2355853B1 (da) |
JP (2) | JP5746629B2 (da) |
KR (1) | KR101726715B1 (da) |
CN (1) | CN102245214B (da) |
AU (1) | AU2009301646B2 (da) |
CA (2) | CA2739078C (da) |
DK (1) | DK2355853T3 (da) |
ES (1) | ES2617913T3 (da) |
HU (1) | HUE030895T2 (da) |
IL (2) | IL212053A (da) |
MY (1) | MY155629A (da) |
NZ (2) | NZ603964A (da) |
PT (1) | PT2355853T (da) |
SG (1) | SG195531A1 (da) |
SI (1) | SI2355853T1 (da) |
WO (1) | WO2010040188A1 (da) |
ZA (1) | ZA201102501B (da) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010040187A1 (en) * | 2008-10-10 | 2010-04-15 | The Bionic Ear Institute | Polymer-bioactive agent conjugates |
US8889193B2 (en) | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
EP2569015A1 (en) | 2010-05-14 | 2013-03-20 | Iberhospitex S.A. | Compounds for the synthesis of biostable polyurethane, polyurea or polyurea urethane polymers |
CA2804842A1 (en) | 2010-07-09 | 2012-01-12 | Board Of Regents Of The University Of Texas System | Biodegradable scaffolds |
WO2012039979A2 (en) | 2010-09-10 | 2012-03-29 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
WO2012109363A2 (en) | 2011-02-08 | 2012-08-16 | The Johns Hopkins University | Mucus penetrating gene carriers |
CN104936620B (zh) | 2012-01-19 | 2019-08-09 | 约翰霍普金斯大学 | 增强粘膜渗透的纳米粒子调配物 |
EP2820067B1 (en) | 2012-03-01 | 2023-02-15 | The University of Akron | Biodegradable polymers with pendant functional groups attached through amide bonds |
CN104363924B (zh) | 2012-03-16 | 2018-04-17 | 约翰霍普金斯大学 | 用于递送hif‑1抑制剂的控制释放调配物 |
CA2867203C (en) * | 2012-03-16 | 2016-09-20 | The Johns Hopkins University | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
KR102140989B1 (ko) | 2012-05-03 | 2020-08-04 | 칼라 파마슈티컬스, 인크. | 개선된 점막 수송을 나타내는 제약 나노입자 |
CA2871745C (en) | 2012-05-03 | 2023-01-24 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US9889208B2 (en) | 2012-05-04 | 2018-02-13 | The Johns Hopkins University | Lipid-based drug carriers for rapid penetration through mucus linings |
PT2863921T (pt) * | 2012-06-26 | 2018-07-17 | Polyactiva Pty Ltd | Conjugado de polímero-aine |
CN102827035A (zh) * | 2012-08-21 | 2012-12-19 | 江苏恒祥化工有限责任公司 | 一种1,4-环己烷二异氰酸酯的合成方法 |
US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
US10113033B2 (en) | 2013-03-08 | 2018-10-30 | Polyactiva Pty Ltd | Polymer conjugate for delivery of a bioactive agent |
WO2014134689A1 (en) | 2013-03-08 | 2014-09-12 | Polyactiva Pty Ltd | Polymer conjugate for delivery of a bioactive agent |
ES2773179T3 (es) * | 2013-03-15 | 2020-07-09 | Ripple Therapeutics Corp | Artículo médico recubierto para liberación de fármacos |
US9572832B2 (en) * | 2013-08-29 | 2017-02-21 | Holy Stone Healthcare Co., Ltd. | Compound of glycosaminoglycan and its fabrication method as well as application |
WO2015127368A1 (en) | 2014-02-23 | 2015-08-27 | The Johns Hopkins University | Hypotonic microbicidal formulations and methods of use |
US10335500B2 (en) | 2014-05-12 | 2019-07-02 | The Johns Hopkins University | Highly stable biodegradable gene vector platforms for overcoming biological barriers |
CN104031248B (zh) * | 2014-05-28 | 2016-09-07 | 博瑞生物医药(苏州)股份有限公司 | 侧链含双硫五元环功能基团的碳酸酯聚合物及其应用 |
CN105770900B (zh) * | 2014-05-28 | 2018-11-02 | 博瑞生物医药(苏州)股份有限公司 | 侧链含双硫五元环功能基团的碳酸酯聚合物的应用 |
CN104004001B (zh) * | 2014-05-28 | 2016-03-30 | 苏州大学 | 含双硫五元环功能基团的环状碳酸酯单体及其制备方法 |
US9359316B1 (en) * | 2014-11-25 | 2016-06-07 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists |
US11634384B2 (en) | 2014-11-25 | 2023-04-25 | Concentric Analgesics, Inc. | Prodrugs of phenolic TRPV1 agonists |
CA2974715C (en) | 2015-01-27 | 2020-05-05 | The Johns Hopkins University | Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces |
CN108472273A (zh) * | 2015-09-11 | 2018-08-31 | 波利艾克蒂瓦有限公司 | 包含生物活性剂的聚合物缀合物 |
KR20180054627A (ko) | 2015-09-21 | 2018-05-24 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 서방형 올란자핀 제제 |
WO2017205534A1 (en) | 2016-05-25 | 2017-11-30 | Concentric Analgesics, Inc. | Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia |
CN108532126B (zh) * | 2017-03-02 | 2021-04-16 | 江苏华龙无纺布有限公司 | 一种抗菌性生物可降解聚酯无纺布及制备方法 |
NZ756626A (en) | 2017-03-14 | 2022-10-28 | Polyactiva Pty Ltd | Drug-polymer conjugate |
US11696955B2 (en) | 2017-03-14 | 2023-07-11 | Polyactiva Pty Ltd | Drug-polymer conjugate |
US11207417B2 (en) | 2017-03-14 | 2021-12-28 | Polyactiva Pty Ltd | Drug-polymer conjugate |
JP2020511483A (ja) | 2017-03-20 | 2020-04-16 | テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーTeva Pharmaceuticals International GmbH | 徐放性オランザピン製剤 |
US11116211B2 (en) | 2018-03-09 | 2021-09-14 | The University Of Akron | Modification of segmented polyurethane properties by copolymerizing with pendant functionalized diols |
EP3721857A1 (en) * | 2019-04-11 | 2020-10-14 | Dentsply DeTrey GmbH | Dental composition |
RU2737425C1 (ru) * | 2020-02-17 | 2020-11-30 | Елена Евгеньевна Масталыгина | Мульчирующая биоразлагаемая полимерная пленка и способ ее получения (варианты) |
EP4146664A2 (en) | 2020-05-01 | 2023-03-15 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
US20240100012A1 (en) | 2021-01-18 | 2024-03-28 | Mark Hasleton | Pharmaceutical dosage form |
CA3227324A1 (en) | 2021-07-06 | 2023-01-12 | Mark Hasleton | Treatment of serotonin reuptake inhibitor withdrawal syndrome |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0874643B1 (en) * | 1996-02-15 | 2001-11-21 | J. Paul Santerre | Bioresponsive pharmacologically-active polymers and articles made therefrom |
US20040091886A1 (en) | 2000-09-21 | 2004-05-13 | Moore Jeffrey C. | Method for generating recombinant polynucleotides |
AR032052A1 (es) * | 2000-12-29 | 2003-10-22 | Artimplant Ab | Polimero lineal de bloques, procedimiento para su preparacion, su uso, implantes, material para relleno, composiciones farmaceuticas y material polimerico poroso que comprenden dicho polimero lineal de bloques |
CA2349989A1 (en) * | 2001-06-07 | 2002-12-07 | Paul J. Santerre | Bioactive surface modifiers for polymers and articles made therefrom |
AU2003267540A1 (en) | 2002-08-13 | 2004-02-25 | Sirus Pharmaceuticals Ltd | Biodegradable polymer |
CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
WO2006024953A2 (en) | 2004-08-31 | 2006-03-09 | Pharmacia & Upjohn Company Llc | Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof |
US8445016B2 (en) * | 2006-04-14 | 2013-05-21 | Interface Biologics, Inc. | Grafted polymers and uses thereof |
JP2010501026A (ja) * | 2006-06-30 | 2010-01-14 | インターフェース バイオロジクス,インコーポレーテッド | 生体応答性ポリマー |
SI2068907T1 (en) | 2006-10-04 | 2018-01-31 | Novo Nordisk A/S | Pegylated sugars and glycopeptides are associated with glycerol |
CA2715815A1 (en) * | 2008-02-15 | 2009-08-20 | University Of Southern Mississippi | Monomers and polymers with covalently-attached active ingredients |
-
2009
- 2009-10-09 CN CN200980149813.4A patent/CN102245214B/zh active Active
- 2009-10-09 EP EP09818693.5A patent/EP2355853B1/en active Active
- 2009-10-09 WO PCT/AU2009/001342 patent/WO2010040188A1/en active Application Filing
- 2009-10-09 CA CA2739078A patent/CA2739078C/en active Active
- 2009-10-09 NZ NZ603964A patent/NZ603964A/en unknown
- 2009-10-09 ES ES09818693.5T patent/ES2617913T3/es active Active
- 2009-10-09 JP JP2011530332A patent/JP5746629B2/ja active Active
- 2009-10-09 AU AU2009301646A patent/AU2009301646B2/en active Active
- 2009-10-09 PT PT98186935T patent/PT2355853T/pt unknown
- 2009-10-09 DK DK09818693.5T patent/DK2355853T3/da active
- 2009-10-09 HU HUE09818693A patent/HUE030895T2/en unknown
- 2009-10-09 SG SG2013075163A patent/SG195531A1/en unknown
- 2009-10-09 KR KR1020117010532A patent/KR101726715B1/ko active IP Right Grant
- 2009-10-09 NZ NZ592139A patent/NZ592139A/xx unknown
- 2009-10-09 MY MYPI2011001469A patent/MY155629A/en unknown
- 2009-10-09 SI SI200931618A patent/SI2355853T1/sl unknown
- 2009-10-09 CA CA2949337A patent/CA2949337C/en active Active
-
2011
- 2011-03-31 IL IL212053A patent/IL212053A/en active IP Right Grant
- 2011-04-05 ZA ZA2011/02501A patent/ZA201102501B/en unknown
-
2013
- 2013-12-17 IL IL229996A patent/IL229996A/en active IP Right Grant
-
2015
- 2015-05-08 JP JP2015095863A patent/JP6290823B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
KR101726715B1 (ko) | 2017-04-13 |
EP2355853A1 (en) | 2011-08-17 |
WO2010040188A1 (en) | 2010-04-15 |
AU2009301646A1 (en) | 2010-04-15 |
AU2009301646B2 (en) | 2013-09-05 |
CN102245214A (zh) | 2011-11-16 |
JP2015180651A (ja) | 2015-10-15 |
ES2617913T3 (es) | 2017-06-20 |
WO2010040188A9 (en) | 2010-06-17 |
PT2355853T (pt) | 2017-03-15 |
CN102245214B (zh) | 2014-10-29 |
SI2355853T1 (sl) | 2017-04-26 |
JP2012505161A (ja) | 2012-03-01 |
EP2355853A4 (en) | 2014-01-15 |
CA2949337C (en) | 2019-03-26 |
ZA201102501B (en) | 2011-11-30 |
IL212053A0 (en) | 2011-06-30 |
CA2739078C (en) | 2017-01-03 |
KR20110091854A (ko) | 2011-08-16 |
IL212053A (en) | 2015-11-30 |
IL229996A0 (en) | 2014-01-30 |
JP5746629B2 (ja) | 2015-07-08 |
CA2739078A1 (en) | 2010-04-15 |
JP6290823B2 (ja) | 2018-03-07 |
CA2949337A1 (en) | 2010-04-15 |
SG195531A1 (en) | 2013-12-30 |
MY155629A (en) | 2015-11-13 |
IL229996A (en) | 2016-06-30 |
HUE030895T2 (en) | 2017-06-28 |
NZ592139A (en) | 2013-03-28 |
NZ603964A (en) | 2014-12-24 |
EP2355853B1 (en) | 2016-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2355853T3 (da) | Bionedbrydelige polymer-bioaktivt fragmentkonjugater | |
WO2012139164A1 (en) | Polymer conjugated prostaglandin analogues | |
EP2863921B1 (en) | Polymer-nsaid conjugate | |
EP2340271A1 (en) | Polymer-bioactive agent conjugates | |
AU2012258480B2 (en) | Biodegradable polymer - bioactive moiety conjugates | |
US20120252967A1 (en) | Polyurethanes | |
DK2340271T3 (da) | Konjugater af polymer-bioaktivt middel |